Cardiologists reveal the unexpected symptoms of clogged arteries and underlying heart disease that you should know about.

More than 60 million American women have heart disease. "The statistics haven't improved enough," a women's heart doctor told ...

Abbott will be trying its hand in the growing field of intravascular lithotripsy, with a clinical study to examine an unnamed ...

Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) for its Coronary Intravascular Lithotripsy (IVL) System to ...

Coronary artery disease (CAD), or the narrowing of the coronary arteries, is the leading cause of morbidity and mortality throughout the world. Atherosclerosis, or the buildup of plaque in the ...

Abbott (ABT) announced that the U.S. Food and Drug Administration, FDA, has approved an investigational device exemption, IDE, for its Coronary ...

In current European and American revascularization guidelines, RA grafts are now strongly endorsed as the second conduit for ...

Abbott has announced that the U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) ...

Johnson & Johnson and Boston Scientific have also recently made moves to sell their own coronary intravascular lithotripsy ...

Signals from the epicardium are essential for fetal coronary lymphangiogenesis. VEGFC and VEGFD produced by the epicardium ...

Sir William Osler was a wise old owl in explaining medical matters. He was a professor of medicine at McGill University in Montreal, John Hopkins University in Baltimore, and finally ...

Abbott (NYSE: ABT) received FDA investigational device exemption (IDE) approval for its coronary intravascular lithotripsy ...